Group One Trading
LKFT

Group One Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Group One Trading’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$527K Buy
17,577
+12,495
+246% +$355K ﹤0.01% 3449
2026
Q1 		$152K Buy
+5,082
New +$168K ﹤0.01% 4348
2025
Q2 		– Sell
-3,135
Closed -$84K – 8169
2025
Q1 		$78.8K Buy
+3,135
New +$79.2K ﹤0.01% 4788
2024
Q3 		– Sell
-2,100
Closed -$57.2K – 6889
2024
Q2 		$52K Sell
2,100
-897
-30% -$25.5K ﹤0.01% 4504
2024
Q1 		$96.5K Sell
2,997
-16,973
-85% -$631K ﹤0.01% 4191
2023
Q4 		$812K Buy
19,970
+19,874
+20,702% +$731K ﹤0.01% 2665
2023
Q3 		$3.32K Sell
96
-12,270
-99% -$478K ﹤0.01% 6876
2023
Q2 		$503K Sell
12,366
-16,461
-57% -$671K ﹤0.01% 3013
2023
Q1 		$1.11M Buy
28,827
+21,969
+320% +$903K ﹤0.01% 2044
2022
Q4 		$304K Buy
6,858
+1,364
+25% +$57.4K ﹤0.01% 3488
2022
Q3 		$234K Sell
5,494
-12,776
-70% -$655K ﹤0.01% 3980
2022
Q2 		$1.02M Buy
18,270
+17,628
+2,746% +$1.05M ﹤0.01% 2744
2022
Q1 		$40K Buy
+642
New +$39.3K ﹤0.01% 6270
2021
Q4 		– Sell
-2,368
Closed -$124K – 8424
2021
Q3 		$125K Sell
2,368
-13,026
-85% -$773K ﹤0.01% 5681
2021
Q2 		$1.06M Sell
15,394
-24,142
-61% -$1.84M ﹤0.01% 3341
2021
Q1 		$3.05M Buy
39,536
+39,187
+11,228% +$3.61M ﹤0.01% 2019
2020
Q4 		$35K Sell
349
-21,398
-98% -$2.62M ﹤0.01% 5218
2020
Q3 		$3.09M Buy
21,747
+3,472
+19% +$579K 0.01% 1249
2020
Q2 		$3.6M Sell
18,275
-6,351
-26% -$1.32M 0.02% 1032
2020
Q1 		$4.83M Buy
24,626
+9,984
+68% +$2.15M 0.04% 558
2019
Q4 		$3.03M Buy
14,642
+2,549
+21% +$471K 0.02% 973
2019
Q3 		$1.85M Buy
+12,093
New +$1.98M 0.01% 1268
2019
Q2 		– Sell
-1,062
Closed -$126K – 5087
2019
Q1 		$125K Sell
1,062
-3,100
-74% -$313K ﹤0.01% 3019
2018
Q4 		$382K Buy
4,162
+4,004
+2,534% +$406K ﹤0.01% 2181
2018
Q3 		$18K Buy
+158
New +$16.7K ﹤0.01% 4422

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Group One Trading's LKFT Position: Q2 2026 in Review

Group One Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 246% in Q2 2026, buying an estimated $355K and bringing the position to 17,577 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #3449.

Group One Trading first reported a position in LKFT in Q3 2018 and has held it in 25 quarters since. The position peaked at $4.83M in Q1 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Group One Trading held 17,577 shares of Lakefront Biotherapeutics American Depositary Shares worth $527K as of Q2 2026.
  • Group One Trading bought 12,495 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $355K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3449 holding.
  • Group One Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 25 quarters since.
  • Group One Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.83M in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.